Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics. (2020)
Attributed to:
Understanding complexity of post-translation modifications by enhancing UK capability for top-down proteomics
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/bcj20200309
PubMed Identifier: 32501498
Publication URI: http://europepmc.org/abstract/MED/32501498
Type: Journal Article/Review
Volume: 477
Parent Publication: The Biochemical journal
Issue: 13
ISSN: 0264-6021